| Dr Thomas Mellow, MD | |
|
887 Congress St, Suite 320, Portland, ME 04102-3100 | |
| (207) 662-5522 | |
| (207) 662-5527 |
| Full Name | Dr Thomas Mellow |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Pulmonology |
| Location | 887 Congress St, Portland, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003846361 | NPI | - | NPPES |
| 331790099 | Medicaid | ME | |
| 30203388 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 016021 (Maine) | Secondary |
| 2080P0214X | Pediatrics - Pediatric Pulmonology | 016021 (Maine) | Primary |
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144090 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000191 |
News Archive
Dana Gray, PA-C, of Portland, Ore., along with his physician partner, Jonathan Hill, MD, received the American Academy of Physician Assistants' 2010 Physician-PA Partnership Award at the organization's 38th Annual Physician Assistant Conference in Atlanta yesterday. The team has provided quality, broad-based trauma and cardiothoracic care to medically underserved populations in the Portland area for more than 15 years.
The greatest research project on cancer biomarkers is to start in the next months. The new scientific research will open new frontiers in the field of prevention of two most relevant cancer: prostate cancer and ovarian cancer. The research project, which also includes an important prevention programme, is named "AVIS donates health" (AVIS is the Italian most important blood donors association) and is supported by Fondazione Abo - Application of biotechnologies in Oncology, Avis, Lilt (Italiana League for the fight against cancer) and by the three scientific societies of gynecologists and urologists.
The function of tubular organs like the kidneys, lungs, and vessels of the vascular system is critically dependent on the length and diameter of the tubular branches of which they are composed.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
› Verified 3 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Dana Gray, PA-C, of Portland, Ore., along with his physician partner, Jonathan Hill, MD, received the American Academy of Physician Assistants' 2010 Physician-PA Partnership Award at the organization's 38th Annual Physician Assistant Conference in Atlanta yesterday. The team has provided quality, broad-based trauma and cardiothoracic care to medically underserved populations in the Portland area for more than 15 years.
The greatest research project on cancer biomarkers is to start in the next months. The new scientific research will open new frontiers in the field of prevention of two most relevant cancer: prostate cancer and ovarian cancer. The research project, which also includes an important prevention programme, is named "AVIS donates health" (AVIS is the Italian most important blood donors association) and is supported by Fondazione Abo - Application of biotechnologies in Oncology, Avis, Lilt (Italiana League for the fight against cancer) and by the three scientific societies of gynecologists and urologists.
The function of tubular organs like the kidneys, lungs, and vessels of the vascular system is critically dependent on the length and diameter of the tubular branches of which they are composed.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Mellow, MD 301 Us Route 1, Scarborough, ME 04074-7609 Ph: (207) 396-8600 | Dr Thomas Mellow, MD 887 Congress St, Suite 320, Portland, ME 04102-3100 Ph: (207) 662-5522 |
News Archive
Dana Gray, PA-C, of Portland, Ore., along with his physician partner, Jonathan Hill, MD, received the American Academy of Physician Assistants' 2010 Physician-PA Partnership Award at the organization's 38th Annual Physician Assistant Conference in Atlanta yesterday. The team has provided quality, broad-based trauma and cardiothoracic care to medically underserved populations in the Portland area for more than 15 years.
The greatest research project on cancer biomarkers is to start in the next months. The new scientific research will open new frontiers in the field of prevention of two most relevant cancer: prostate cancer and ovarian cancer. The research project, which also includes an important prevention programme, is named "AVIS donates health" (AVIS is the Italian most important blood donors association) and is supported by Fondazione Abo - Application of biotechnologies in Oncology, Avis, Lilt (Italiana League for the fight against cancer) and by the three scientific societies of gynecologists and urologists.
The function of tubular organs like the kidneys, lungs, and vessels of the vascular system is critically dependent on the length and diameter of the tubular branches of which they are composed.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
› Verified 3 days ago
Rushika M Conroy, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 41 Donald B Dean Dr Ste A, Portland, ME 04106 Phone: 207-661-6064 | |
Michael Alexander Ferguson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Mmc Picu, Portland, ME 04102 Phone: 207-662-6711 | |
Dr. Rute S Rothwell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-7060 | |
Kenneth Lombard, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 887 Congress St, Suite 410b, Portland, ME 04102 Phone: 207-662-5522 Fax: 207-662-5526 | |
David F Cox, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2353 | |
Marie H Tanzer, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 887 Congress St, Suite 320, Portland, ME 04102 Phone: 207-662-5522 Fax: 207-662-5527 |